These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 22237010

  • 1. Increased cancer risks in myotonic dystrophy.
    Win AK, Perattur PG, Pulido JS, Pulido CM, Lindor NM.
    Mayo Clin Proc; 2012 Feb; 87(2):130-5. PubMed ID: 22237010
    [Abstract] [Full Text] [Related]

  • 2. Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.
    Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM.
    Muscle Nerve; 2018 Oct; 58(4):517-522. PubMed ID: 30028904
    [Abstract] [Full Text] [Related]

  • 3. A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy.
    Abbott D, Johnson NE, Cannon-Albright LA.
    Muscle Nerve; 2016 Oct; 54(4):783-5. PubMed ID: 27064430
    [Abstract] [Full Text] [Related]

  • 4. Brain tumors in patients with myotonic dystrophy: a population-based study.
    Gadalla SM, Pfeiffer RM, Kristinsson SY, Björkholm M, Landgren O, Greene MH.
    Eur J Neurol; 2016 Mar; 23(3):542-7. PubMed ID: 26508558
    [Abstract] [Full Text] [Related]

  • 5. Cancer risk among patients with myotonic muscular dystrophy.
    Gadalla SM, Lund M, Pfeiffer RM, Gørtz S, Mueller CM, Moxley RT, Kristinsson SY, Björkholm M, Shebl FM, Hilbert JE, Landgren O, Wohlfahrt J, Melbye M, Greene MH.
    JAMA; 2011 Dec 14; 306(22):2480-6. PubMed ID: 22166607
    [Abstract] [Full Text] [Related]

  • 6. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
    Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE.
    J Autoimmun; 2013 May 14; 42():130-5. PubMed ID: 23410586
    [Abstract] [Full Text] [Related]

  • 7. Cancer Risk in Patients With Muscular Dystrophy and Myotonic Dystrophy: A Register-Based Cohort Study.
    Maya-González C, Tettamanti G, Taylan F, Skarin Nordenvall A, Sejersen T, Nordgren A.
    Neurology; 2024 Oct 22; 103(8):e209883. PubMed ID: 39298705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 10. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.
    Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA.
    J Natl Cancer Inst; 2012 Sep 19; 104(18):1363-72. PubMed ID: 22933731
    [Abstract] [Full Text] [Related]

  • 11. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome.
    Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J, Macrae FA, Parry S, Kalady MF, Baron JA, Ahnen DJ, Marchand LL, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Jenkins MA.
    J Natl Cancer Inst; 2013 Feb 20; 105(4):274-9. PubMed ID: 23385444
    [Abstract] [Full Text] [Related]

  • 12. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX, Nelson RA, Kim JY, Raz DJ.
    Clin Lung Cancer; 2017 Sep 20; 18(5):543-550.e3. PubMed ID: 28412093
    [Abstract] [Full Text] [Related]

  • 13. Survival patterns and cancer determinants in families with myotonic dystrophy type 1.
    Best AF, Hilbert JE, Wood L, Martens WB, Nikolenko N, Marini-Bettolo C, Lochmüller H, Rosenberg PS, Moxley RT, Greene MH, Gadalla SM.
    Eur J Neurol; 2019 Jan 20; 26(1):58-65. PubMed ID: 30051542
    [Abstract] [Full Text] [Related]

  • 14. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
    Lund M, Diaz LJ, Ranthe MF, Petri H, Duno M, Juncker I, Eiberg H, Vissing J, Bundgaard H, Wohlfahrt J, Melbye M.
    Eur Heart J; 2014 Aug 21; 35(32):2158-64. PubMed ID: 24742887
    [Abstract] [Full Text] [Related]

  • 15. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working GroupAIRTUM Working Group: tumori.infantili@registri-tumori.it..
    Epidemiol Prev; 2013 Aug 21; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [Abstract] [Full Text] [Related]

  • 16. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.
    J Natl Cancer Inst; 2016 Feb 21; 108(2):. PubMed ID: 26538627
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S, Swiss HIV Cohort.
    J Natl Cancer Inst; 2005 Mar 16; 97(6):425-32. PubMed ID: 15770006
    [Abstract] [Full Text] [Related]

  • 19. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 16; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 20. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
    Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM.
    Ann Clin Transl Neurol; 2019 Aug 16; 6(8):1510-1518. PubMed ID: 31402615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.